annual EBITDA:
-$58.55M+$13.86M(+19.14%)Summary
- As of today (August 22, 2025), LENZ annual EBITDA is -$58.55 million, with the most recent change of +$13.86 million (+19.14%) on December 31, 2024.
- During the last 3 years, LENZ annual EBITDA has risen by +$1.16 million (+1.94%).
- LENZ annual EBITDA is now -201803.45% below its all-time high of -$29.00 thousand, reached on December 1, 2019.
Performance
LENZ EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$16.84M+$57.00K(+0.34%)Summary
- As of today (August 22, 2025), LENZ quarterly EBITDA is -$16.84 million, with the most recent change of +$57.00 thousand (+0.34%) on June 30, 2025.
- Over the past year, LENZ quarterly EBITDA has dropped by -$2.50 million (-17.47%).
- LENZ quarterly EBITDA is now -13815.70% below its all-time high of -$121.00 thousand, reached on March 1, 2020.
Performance
LENZ quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$61.87M-$2.50M(-4.22%)Summary
- As of today (August 22, 2025), LENZ TTM EBITDA is -$61.87 million, with the most recent change of -$2.50 million (-4.22%) on June 30, 2025.
- Over the past year, LENZ TTM EBITDA has increased by +$13.39 million (+17.80%).
- LENZ TTM EBITDA is now -51030.58% below its all-time high of -$121.00 thousand, reached on March 1, 2020.
Performance
LENZ TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
LENZ EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +19.1% | -17.5% | +17.8% |
| 3 y3 years | +1.9% | +31.9% | +24.3% |
| 5 y5 years | -10000.0% | -1204.3% | -4281.6% |
LENZ EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +39.8% | -33.5% | +32.6% | -5.7% | +36.4% |
| 5 y | 5-year | <-9999.0% | +39.8% | -1204.3% | +32.6% | -4281.6% | +36.4% |
| alltime | all time | <-9999.0% | +39.8% | <-9999.0% | +32.6% | <-9999.0% | +36.4% |
LENZ EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$16.84M(-0.3%) | -$61.87M(+4.2%) |
| Mar 2025 | - | -$16.89M(+11.2%) | -$59.36M(+1.4%) |
| Dec 2024 | -$58.55M(-19.1%) | -$15.20M(+17.5%) | -$58.55M(-14.3%) |
| Sep 2024 | - | -$12.94M(-9.8%) | -$68.34M(-9.2%) |
| Jun 2024 | - | -$14.33M(-10.9%) | -$75.26M(-0.8%) |
| Mar 2024 | - | -$16.08M(-35.6%) | -$75.88M(+4.8%) |
| Dec 2023 | -$72.41M(-25.6%) | -$24.98M(+25.8%) | -$72.41M(+0.6%) |
| Sep 2023 | - | -$19.86M(+32.8%) | -$71.96M(-5.4%) |
| Jun 2023 | - | -$14.96M(+18.6%) | -$76.08M(-11.4%) |
| Mar 2023 | - | -$12.61M(-48.6%) | -$85.84M(-11.8%) |
| Dec 2022 | -$97.29M | - | - |
| Dec 2022 | - | -$24.53M(+2.3%) | -$97.29M(+6.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$23.99M(-2.9%) | -$91.70M(+12.2%) |
| Jun 2022 | - | -$24.71M(+2.7%) | -$81.76M(+9.8%) |
| Mar 2022 | - | -$24.07M(+27.1%) | -$74.48M(+24.8%) |
| Dec 2021 | -$59.71M(+346.3%) | -$18.94M(+34.8%) | -$59.70M(+21.9%) |
| Sep 2021 | - | -$14.05M(-19.4%) | -$48.96M(+26.6%) |
| Jun 2021 | - | -$17.43M(+87.9%) | -$38.68M(+71.6%) |
| Mar 2021 | - | -$9.28M(+13.1%) | -$22.54M(+68.4%) |
| Dec 2020 | -$13.38M(>+9900.0%) | -$8.20M(+117.9%) | -$13.38M(+158.5%) |
| Sep 2020 | - | -$3.76M(+191.6%) | -$5.18M(+266.6%) |
| Jun 2020 | - | -$1.29M(+966.9%) | -$1.41M(+1066.9%) |
| Mar 2020 | - | -$121.00K | -$121.00K |
| Dec 2019 | -$29.00K | - | - |
FAQ
- What is LENZ Therapeutics, Inc. annual EBITDA?
- What is the all time high annual EBITDA for LENZ Therapeutics, Inc.?
- What is LENZ Therapeutics, Inc. annual EBITDA year-on-year change?
- What is LENZ Therapeutics, Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for LENZ Therapeutics, Inc.?
- What is LENZ Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is LENZ Therapeutics, Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for LENZ Therapeutics, Inc.?
- What is LENZ Therapeutics, Inc. TTM EBITDA year-on-year change?
What is LENZ Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of LENZ is -$58.55M
What is the all time high annual EBITDA for LENZ Therapeutics, Inc.?
LENZ Therapeutics, Inc. all-time high annual EBITDA is -$29.00K
What is LENZ Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, LENZ annual EBITDA has changed by +$13.86M (+19.14%)
What is LENZ Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of LENZ is -$16.84M
What is the all time high quarterly EBITDA for LENZ Therapeutics, Inc.?
LENZ Therapeutics, Inc. all-time high quarterly EBITDA is -$121.00K
What is LENZ Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, LENZ quarterly EBITDA has changed by -$2.50M (-17.47%)
What is LENZ Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of LENZ is -$61.87M
What is the all time high TTM EBITDA for LENZ Therapeutics, Inc.?
LENZ Therapeutics, Inc. all-time high TTM EBITDA is -$121.00K
What is LENZ Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, LENZ TTM EBITDA has changed by +$13.39M (+17.80%)